 |
| Luminex microspheres and hardware are used by our partners to develop reagents and kits. For more information on our partners' xMAP reagent products, click here |
 |
 |
 |
 |
 |
| The Luminex 200™ is designed to meet the multiplex testing needs of clinical and research laboratory professionals. |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
| The Luminex 100 IS™ System is a flexible analyzer based on the principles of flow cytometry. |
|
|
 |
 |
 |
Proven – Built on proven, existing technology; flow cytometry, microspheres, lasers, digital signal processing and traditional chemistry |
 |
Multiplexing - Up to 100 bioassays per well; internal controls allowable in each well |
 |
Small Sample Size - Less than 50 µL of sample for up to 100 results |
 |
Reliability - Robust optics and fluidics for minimum downtime
|
 |
Template-based Software - Designed for use with kits; simple assay set up, reading, and analysis |
 |
Reproducibility - Suspended microspheres give consistent results and allow for easy quality control |
 |
Versatility - Same platform can be used for immunoassay, genotyping, gene expression, or enzyme assays |
 |
Accuracy - Quantitative results over a 3 to 4 log dynamic range, with strong concordance to ELISA and Mass Spectrometry |
 |
Diagnostic Use - For use with partners’ xMAP-based 510(k) cleared kits
|
|
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
| The Luminex High Throughput Screening System™ (HTS) is designed to perform hundreds of thousands of individual bioassays per day. |
|
|
|
|
 |
 |
 |
 |
 |
For Research Use Only.
In conjunction with the FlexmiR MicroRNA Labeling Kit, the human panel measures the expression of the miRBase Sequence database human miRNA sequences for 20 samples. |
 |
 |
Luminex 200 System
Luminex 100 IS System |
|
|
 |
|
 |
|
 |
|
|
 |
|
|
 |
|
 |
 |
 |
For Research Use Only.
NEW! The set of reagents, exclusive of the microspheres, necessary for performing the hybridization and detection portions of the assay. |
 |
 |
Luminex 200 System
Luminex 100 IS System |
|
|
 |
|
|
|
 |
 |
|
|
 |
|
|
|
 |
|
|
|
|